Nitric Oxide Trial Combined Endpoint Should Include ECMO Procedure
Executive Summary
Trials of inhaled nitric oxide for treatment of neonatal hypoxic respiratory failure should use a combined endpoint that includes initiation of extracorporeal membrane oxygenation (ECMO), FDA's Cardio-Renal Drugs Advisory Committee said at its April 9 meeting.